Previous 10 | Next 10 |
Nano-X Imaging (NASDAQ:NNOX), an Israel-based developer of medical imaging technology, has lost ~8% in the pre-market Thursday after the company reported lower than expected revenue with its 1Q 2022 financials. During its first full quarter of revenue generation, Nano-X (NNOX) repor...
Nano-X Imaging press release (NASDAQ:NNOX): Q1 Revenue of $1.81M (+38% Q/Q). Non-GAAP gross profit of $ 0.7 million for the three months ended March 31, 2022, which represents a gross profit margin of approximately 39% on a non-GAAP basis. As of March 31, 2022, the Company had $73.7M of cash,...
Reports progress towards global supply chain development Ended the first quarter of 2022 with cash and marketable securities of $139.5 million Management to host conference call and webcast today, May 19, 2022 at 8:30 AM ET NANO-X IMAGING LTD (NASDAQ: NNOX) (...
NANO-X IMAGING LTD (" Nanox " or the " Company ," Nasdaq: NNOX) will report its results for the first quarter ended March 31, 2022 before market on Thursday, May 19, 2022. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call...
NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the U.S. Securities and Exchange Commission (“SECȁ...
Nano-X Imaging (NASDAQ:NNOX) on Thursday said its unit Nanox.AI got a U.S. Food and Drug Administration (FDA) premarket medical device clearance for its HealthOST device, an AI software that provides clinicians with a spinal analysis to help in the treatment of musculoskeletal disease, such a...
HealthOST is a fully automated spinal analysis of vertebral compression fractures and low bone density often associated with osteoporosis NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that i...
Shares of Nano-X Imaging (NASDAQ: NNOX) , or simply called Nanox, continued jumping higher on Tuesday after the company announced that it's opened a new facility to aid in the production of its medical devices. The stock was already up roughly 20% following the release of financial ...
Gainers: Sunshine Biopharma (SBFM) +181%. Nano-X Imaging (NNOX) +15%. Arcus Biosciences (RCUS) +13%. Cue Biopharma (CUE) +11%. Dermata Therapeutics (DRMA) +6%. Losers: IMARA (IMRA) -35%. GBS (GBS) -15%. Precipio (PRPO) -13%. Cassava Sciences (SAVA) -10%...
Nano-X Imaging (NASDAQ:NNOX) has opened its new semiconductor chip fabrication plant in South Korea. The facility is operational, opened on schedule, and will be the main production site of Nanox micro-electro-mechanical systems known as Nanox.SOURCE. Company believes these acquisit...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 08:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-12 05:50:00 ET If artificial intelligence (AI) is the new gold rush, Nvidia (NASDAQ: NVDA) is the preeminent supplier of picks and shovels. The strong demand for Nvidia's graphics processing units (GPUs) is mind-boggling. But Nvidia isn't just helping major corporati...
PETACH TIKVA, Israel, June 25, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that data from five studies supporting the AI Cardiac Solution (HealthCCSng) of its su...